APOE and Hepatic steatosis: The VLDLr mediates reuptake of VLDL into the liver, and downregulation of Vldlr may therefore contribute to protection from hepatic steatosis by androgens in vivo (35), although this mechanism may be less relevant in our apoE-deficient model.